Elmwood Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
879
+46
+6% +$47K 0.26% 87
2026
Q1
$766K Buy
833
+17
+2% +$17.2K 0.21% 100
2025
Q4
$877K Buy
816
+45
+6% +$43K 0.28% 89
2025
Q3
$588K Buy
771
+132
+21% +$98.2K 0.21% 96
2025
Q2
$498K Buy
639
+1
+0.2% +$777 0.2% 96
2025
Q1
$527K Buy
638
+21
+3% +$17.5K 0.22% 90
2024
Q4
$476K Buy
617
+32
+5% +$26.5K 0.19% 96
2024
Q3
$518K Buy
+585
New +$526K 0.21% 93

Other funds holding LLY

Elmwood Wealth Management's LLY Position: Q2 2026 in Review

Elmwood Wealth Management increased its Eli Lilly (LLY) stake by 5.5% in Q2 2026, buying an estimated $47K and bringing the position to 879 shares worth $1.05M. The position accounts for 0.26% of the portfolio, ranked #87.

Elmwood Wealth Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 887 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elmwood Wealth Management held 879 shares of Eli Lilly worth $1.05M as of Q2 2026.
  • Elmwood Wealth Management bought 46 Eli Lilly shares in Q2 2026, an estimated $47K.
  • Eli Lilly made up 0.26% of Elmwood Wealth Management's portfolio in Q2 2026, its #87 holding.
  • Elmwood Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 887 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elmwood Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.